Minority Institutions' Drug Abuse Research Development Program (MIDARP)
Description:
Estimated Total Program Funding: Up to $350,000 per year in direct costs for 3-5 years.
The purpose of this program is to increase the capacity of minority institutions to conduct research in drug abuse and addiction. Grants will be provided to foster the research career development of racial/ethnic minority faculty, students, and staff who are underrepresented in drug abuse research and to conduct research in the drug abuse and addiction research area. All capacity development and research activities must address scientific areas related to the mission and priorities of the National Institute on Drug Abuse.
The overall goal of this RFP is to develop the capacity of the applicant institution to support drug abuse research through the following objectives:
- provide under-represented minority faculty with drug abuse research knowledge and skill development through the conduct of research projects and other professional development activities
- encourage under-represented minority students to pursue drug abuse research careers by providing them with educational enrichment and research experiences ; and
- strengthen the underlying institutional infrastructure needed to support drug abuse research.
Research in any area of drug abuse research supported by NIDA is permissible. NIDA is interested in biomedical, clinical, and behavioral research and supports research on drug abuse in the following broad areas: epidemiology, etiology, prevention, treatment and services, basic research, and medications development. Research areas of particular interest are on HIV/AIDS as it relates to drug use and abuse and understanding disparities in health related to drug abuse and addiction experienced by racial/ethnic minority populations. Some areas of research such as studies that focus primarily on alcohol use may not be appropriate for primary assignment to NIDA. Applicants are encouraged to consult with NIDA staff before submitting an application to ensure that the chosen area of research focus is appropriate to NIDA's mission.
Each application must have a thematic research focus around which all research and training activities are directed. That is, there must be a common research issue or question (e.g., prevention with young adults, what increases adherence to treatment protocols in African Americans) that unites proposed institutional infrastructure development, faculty and student research development activities, and research projects.
Each applicant must provide
- a description of the institution's current drug abuse research capacity,
- a faculty development plan,
- a student recruitment and development plan,
- research projects,
- an institutional research infrastructure development plan,
- justification for the choice of the proposed Program Director (Principal Investigator),
- the inclusion and description of an external advisory board,
- a letter of institutional commitment signed by a Dean or other institutional official with authority to commit institutional resources, and
- an impact assessment statement.
Sponsor(s):
US Department of Health and Human Services
National Institutes of Health
National Institute on Drug Abuse
Funder's Fund ID: PAR-05-069
Web Page:
Letter of Intent Date: 07/15/2005
Letter of Intent Date: 03/13/2006
Letter of Intent Date: 07/17/2006
Letter of Intent Date: 03/12/2007
Letter of Intent Date: 07/16/2007
Letter of Intent Date: 03/12/2008
Fund Duration:
3-5 years.
Application Process:
Additional instructions for R21 application preparation are available at
grants.nih.gov/grants/guide/pa-files/PA-03-107.html.
For further assistance contact GrantsInfo, Telephone (301) 435-0714, Email:
Grantsinfo@nih.gov.
Applications must have a D&B Data Universal Numbering System (DUNS) number as the universal identifier when applying for Federal grants or cooperative agreements. The D&B number can be obtained by calling (866) 705-5711 or through the web site at
www.dnb.com/us/.
Eligible Locations:
National
Fund Notes:
Application Contact Name:
Gary Fleming, Chief, Grants Mgt. Branch/OPRM
Application Contact Address:
Technical Contact Name:
Technical Contact Address:
Support Types:
Subject Areas:
Audiences:
Eligibility:
Eligibility Notes:
Applications may be submitted by an organization, university or college that meets one of the following criteria regarding minority classification:
In addition, these minority status applicants must demonstrate commitment to under-represented minority research development goals through
http://grants.nih.gov/grants/guide/pa-files/PAR-05-069.html
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity.
Application Due Date: 08/16/2005
Peer Review Date: December, 2005
Council Review Date: May, 2006
Project Start Date: 05/01/2006
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity
Application Due Date: 04/12/2006
Peer Review Date: August, 2006
Council Review Date: February, 2007
Project Start Date: 02/01/2007
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity
Application Due Date: 08/16/2006
Peer Review Date: December, 2006
Council Review Date: May, 2007
Project Start Date: 05/01/2007
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity
Application Due Date: 04/12/2007
Peer Review Date: August, 2007
Council Review Date: February, 2008
Project Start Date: 02/01/2008
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity
Application Due Date: 08/16/2007
Peer Review Date: December, 2007
Council Review Date: May, 2008
Project Start Date: 05/01/2008
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity
Application Due Date: 04/12/2008
Peer Review Date: August, 2008
Council Review Date: February, 2009
Project Start Date: 02/01/2009
Applications must be prepared using the PHS 398 research grant application instructions and forms (rev. 9/2004); The PHS 398 document is available in an interactive format at
grants.nih.gov/grants/funding/phs398/phs398.html.
This is a reissue of PAR-02-016, which was previously released October 22, 2001.
DHHS/NIH/NIDA
6101 Executive Blvd., Rm. 270
Bethesda, MD 20892
United States
E-mail: gfleming@nida.gov
Phone: 301- 443-6710
Fax: 301- 594-6849
Lula Beatty
NIDA, Special Populations Off.
6001 Executive Blvd.
Rm. 4216, MSC 9567
Bethesda, MD 208929567
United States
E-mail: lb75x@nih.gov
Phone: 301- 443-0441
Fax: 301- 480-8179
Research
Behavioral Research
Clinical Research
Drug Abuse
Epidemiological Research
Research Programs
African Americans/Blacks
Asians/Pacific Islanders
Hispanics/Latinos
Injecting Drug Users
Minorities
Native Americans
Substance Abusers
Colleges/Universities
Minority Owned Organizations
Nonprofit Organizations
Tribal Organizations
Institutions applying for this award must demonstrate eligibility through